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Abstract 
Purpose: To explore the issue of counterintuitive data via analysis of a representative case and 
further discussion of those situations in which the data appear to be inconsistent with current 
knowledge. 
Case: 844 postoperative CABG patients, who were extubated within 24 hours of surgery were 
identified in a critical care database (MIMIC-III). Nurse elicited pain scores were documented 
throughout their hospital stay on a scale of 0 to 10. Levels were tracked as mean, median, and 
maximum values, and categorized as no (0/10), mild (1-3), moderate (4-6) and severe pain (7-
10). Regression analysis was employed to analyze the relationship between pain scores and 
outcomes of interest (mortality and hospital LOS). After covariate adjustment, increased levels 
of pain were found to be associated with lower mortality rates and reduced hospital LOS.  
Conclusion: These counterintuitive results for post-CABG pain related outcomes have not been 
previously reported. While not representing strong enough evidence to alter clinical practice, 
confirmed and reliable results such as these should serve as a research trigger and prompt further 
studies into unexpected associations between pain and patient outcomes. With the advent of 
frequent secondary analysis of electronic health records, such counterintuitive data results are 
likely to become more frequent. We discuss the issue of counterintuitive data in extended 
fashion, including possible reasons for, and approaches to, this phenomenon.  
Introduction 
 
What do we mean by counterintuitive data?  It is data that presents unexpected results that may 
clash with common sense or what has been previously published and accepted by the medical 
community. In practice, clinicians have long dealt with such results in individual bits but have 
had the vast advantage of being able to examine the concurrent state of the patient and react in 
real time by repeating a lab test or tracking ongoing monitor data. These responses  function to 
identify the prior result as a non-repeatable error, or as a genuine anomaly. However, this 
approach is not applicable to the context of retrospective data analysis. Furthermore, the 
counterintuitive data revealed in such analyses is likely to be more involved than a single 
aberrant lab or vital sign value. In today’s data driven healthcare system, retrospective data 
analyses are becoming more and more common. We can therefore logically expect to encounter 
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a greater incidence and variety of counterintuitive values and results that are impossible to 
confirm by repetition, difficult to confirm or deny by context, but still require interpretation.  
  
The question then becomes how best to approach such results? Are they incorrect simply because 
they weren’t what was expected?  And was the expectation itself based on subjective 
assumptions or objective conclusions? When our prior expectations are not met, are we dealing 
with truly faulty data, or do our expectations need to be reset by what are actually reliable, but 
counterintuitive, results. For example, we have learned that intensive care practices common in 
the past such as large tidal volume ventilation, the use of pulmonary artery catheters, and the use 
of lidocaine infusions in myocardial infarction led to no benefit or injury.1-3 Were these 
unexpected negative outcomes initially missed because outcomes data was not being carefully 
analyzed, or perhaps ignored or interpreted as counterintuitive to the level of unbelievability? 
How can the situation be dissected retrospectively so that counterintuitive data can be identified 
as truly spurious versus simply not being consistent with our prior experience which may itself 
be faulty and require data driven correction? 
 
In this paper, we explore a case in which the results contradicted previous reports and our 
clinical expectations. Using the Medical Information Mart for Intensive Care-III (MIMIC-III), a 
critical care database that was developed and maintained by the Laboratory for Computational 
Physiology at the Massachusetts Institute of Technology4, we retrospectively selected a cohort of 
patients that underwent a coronary artery bypass graft (CABG) procedure and evaluated the 
effect of perceived pain on mortality and hospital length of stay (LOS). We found that higher 
levels of pain were associated with reduced mortality and reduced LOS, contrary to previous 
reports in which better pain control was associated with better outcomes.  We then discuss 
potential causes of these results and the general issue of dealing with counterintuitive results in 
retrospective data analyses.  
Case 
Population 
We selected patients from the MIMIC database who met all of the following inclusion criteria 
and none of the exclusion criteria. Inclusion criteria included: (1) Adult > 18 years old, (2) who 
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underwent CABG surgery, and (3) was extubated within 24 hours after arrival to the ICU. 
Exclusion criteria were: (1) Non-CABG surgical procedure, and (2) missing data on confounding 
variables. Patients were identified using Current Procedural Terminology (CPT) codes: The 
following CPT codes corresponded to the CABG procedure: 33510 to 33516 for venous grafting 
only for coronary artery bypass, and 33533 to 33548 for arterial grafting for coronary bypass. 
The final study cohort contained 844 patients (Figure 1). 
The MIMC-III database included 1,917 patients who underwent CABG, with 844 meeting the 
study criteria. CABG was chosen for the investigation as it is a common procedure with the 
majority of patients having no or few post-operative complications and relatively predictable 
recoveries.5 Due to the nature of the surgical procedure which requires sternal spreading for 
exposure, there is an expected high analgesic burden immediately after surgery. 
Outcomes 
The primary outcome assessed was mortality at 30 days. Secondary outcomes were mortality at 1 
year and hospital LOS. In the MIMIC database, mortality data for patients who die after hospital 
discharge is derived from the social security death registry.4 
Exposures 
The exposures of interest were pain levels reported by the patient immediately and in the 
subsequent interval after ICU extubation. Pain levels on a scale of 0-10 were regularly self-
reported by patients to ICU nurses and recorded in the database, generating a continuum of 
measurements for each patient. The mean, median, and maximum pain levels were used for 
separate analyses. Concomitant measurements of heart rates, respiratory rates, and systolic blood 
pressures were also compared against their simultaneously recorded pain measurement. Nausea 
and delirium were also tested against our outcomes. The presence of nausea was derived from 
the nursing notes stored in the database. A positive nausea exposure was defined as the mention 
“nausea” or “nauseous” in the nursing note with no negative descriptor, such as “not nauseous” 
or “denies nausea”, attached. Delirium was similarly assessed by looking for mention of 
“delirium”, “delirious”, or “confusion”. Additionally, delirium exposure was considered positive 
if patients had a positive nursing delirium assessment.  
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Covariates 
Several variables were included to control for confounding in the regression models: 
demographic factors, comorbid conditions, and illness severity score on admission to the ICU.6 
Comorbid burden was represented by the Elixhauser index which is determined by the aggregate 
presence or absence of 30 different comorbid conditions as detected by ICD-9 codes.7 Illness 
severity was captured using the Oxford Acute Severity of Illness Score (OASIS), which is 
calculated on admission to the ICU and takes into account age, heart rate, Glasgow coma scale, 
mean arterial pressure, temperature, respiratory rate, ventilatory status, urine output, pre-ICU in-
hospital LOS, and whether or not the patient underwent elective surgery.  Studies have shown 
OASIS is comparable to other illness severity ratings in predicting outcomes such as mortality 
and length of stay.8 
Analysis 
Analysis was carried out using R version 3.4.0 and SAS 9.4. Unconditional logistic regression 
with Fisher’s optimization was used to compare the pain measures with 30-day and 1-year 
mortality. Linear regression was used to model the relationship between mean pain scores and 
hospital LOS. Age, gender (male reference), Elixhauser index, and OASIS score were included 
in the models to account for potential confounders.  In a separate ordinal regression, mean pain 
levels were categorized into four groups of no pain (0/10), mild pain (1-3), moderate pain (3-6), 
and severe pain (7-10) in accordance with the NIH Pain Consortium.9 ANOVA was used to 
determine if there was a significant variation in heart rate, respiratory rate, and/or systolic blood 
pressure, when compared to the concurrent pain assessment. Two sensitivity analyses were 
performed to assess the robustness of the observed effects. The first included the same statistical 
tests in all postoperative CABG patients regardless of duration of intubation. The second 
sensitivity analysis excluded patients who died in the hospital. To add validity to the potential 
associations, falsification hypothesis testing using nausea, a symptom with no known effect on 
clinical outcomes, was performed on the same patient cohort. Assessment of delirium, a 
symptom associated with poorer patient outcomes, was also performed against the outcome 
measures.10 
Results 
The database included 844 patients who underwent a CABG procedure and were extubated 
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within 24 hours. There were 68 patients who on average reported no pain during their ICU stay 
after extubation, 419 with mild pain, 336 with moderate pain, and 21 with severe pain. The 
distribution of patient characteristics, including age, gender, illness acuity on ICU admission 
(OASIS), and comorbidity index is reported in Table 1. There was no significant difference 
noted in the frequency in which pain was assessed in those who experienced lower pain levels 
when compared to those who experienced increased pain levels. The number of comorbidities 
ranged from 0 to 9. Bivariate analysis showed increasing OASIS was significantly associated 
with increased mortality and increased LOS (p < 0.05). 
Bivariate analysis (Figure 2) shows a correlation between increasing pain levels and improved 
outcomes among these patients who had no intra-operative complications and were extubated 
within 24 hours of arrival in the ICU. Higher pain levels for this specific cohort of patients who 
were fast-tracked after CABG were found to be associated with decreased hospital LOS. Those 
who experienced lower levels of pain in the ICU were more likely to be dead at 30 days and 1 
year.  
Multivariate regression analysis was performed to adjust for confounding. Four different models 
using mean, median, and maximum pain scores, and pain categories were tested against the 
clinical outcomes with the results displayed in Table 2. The logistic regression models 
consistently showed that increasing pain was associated with reduced odds of death at 30 days 
and 1 year after adjustment for illness severity and co-morbid conditions. All the linear models 
demonstrated that increasing pain levels were also associated with decreased hospital LOS, 
except for the model that looked at the maximum pain score, which showed an opposite effect. 
No significant variations were noted in heart rate, respiratory rate, or blood pressure with 
increasing pain levels.   
Sensitivity analysis was employed to examine all patients regardless of duration of intubation, 
expanding the sample size to 1889 patients. The results were similar for 30-day mortality and 
hospital LOS as regards effect size and statistical significance; however, the results were not 
statistically significant for 1-year mortality (Table 2). An additional sensitivity analysis excluded 
patients who died in the hospital- these results were consistent with the prior models and were 
statistically significant for hospital LOS, but not for mortality (Table 2). 
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As expected, the presence of nausea was not found to be associated with any impact on outcomes 
in the study cohort. As also would be expected, patients who had delirium had worse 30-day and 
1-year mortality and longer hospital LOS.  
Discussion 
We will first discuss the unexpected results that we observed in the data, and then go on to 
discuss the general issue of counterintuitive data.  Our results indicating that increasing levels of 
patient-reported pain severity post-CABG surgery are associated with better clinical outcomes 
were not consistent with our initial hypothesis that better outcomes would correlate with better 
pain control as per the reported literature. In fact, prior studies have found increased levels of 
pain in the hospital to be associated with increased mortality. 11 
The difference in the study cohort between our study and others in the literature may explain the 
discordance in the findings. Our initial analysis was limited to “fast-tracked” patients after 
CABG: these are patients who did not have intra-operative complications and were extubated 
early in their ICU course. These patients made up 44% of the patients in the database and such 
patients are likely to be increasingly common as fast-track initiative are instituted. Studies that 
have reported worse clinical outcomes associated with post-operative pain did not select for a 
relatively healthy cohort of patients who had been screened and prepared for a successful CABG 
operation. Why would patients with higher levels of pain reported shortly after surgery have 
better outcomes? It is well documented that an increased inflammatory reaction is associated 
with increased pain. Pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α have been 
directly implicated in the physiology of pain.12,13 These cytokines have also been found to be 
directly involved in the process of wound healing through the stimulation of various processes 
such as keratinocyte and fibroblast proliferation and synthesis and breakdown of extracellular 
matrix proteins.14 We suspect that those patients who demonstrated better outcomes were 
mounting a more robust inflammatory response, leading to more pain, but importantly, also to an 
increased ability to heal.  
Another possibility is that the higher pain levels detected represent a kind of proxy for a 
generally better state of health, including superior physiological function of the cardiovascular, 
respiratory, renal, and hepatic systems.  In tandem, these systems act to metabolize and eliminate 
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anesthetic and analgesic drugs so that the net pharmacokinetic result would likely be increased 
susceptibility to pain simply due to less of administered agents remaining at active sites.  
Furthermore, patients with better cardiovascular function would likely have better cerebral 
perfusion with improved central neurological function including pain perception, and thereby 
might have a pharmacodynamic reason for perceiving more pain, as well.  And of course, 
patients who are generally in better overall condition would, all else being roughly equal in terms 
of surgical issues, be expected to manifest better outcomes, as well. These thoughts are 
admittedly speculative and additional research is needed to explore these possibilities.   
Clearly, it is critically important to point out that the goal of clinicians should not be in any way 
to maximize pain to optimize outcomes.  Conventional approaches that aim to control pain 
adequately should be employed.  Our observation is just that - an observation of an association 
and conjectures of possible linking mechanisms but is not intended in any way to drive pain 
management policy in the direction of tolerating undertreated pain. 
We performed sensitivity analyses, one including all patients regardless of duration of 
mechanical ventilation post-operatively, and another excluding patients who died during 
hospitalization, and reached similar conclusions. When excluding in-hospital deaths, we 
discovered the 30-day mortality rate had a similar odds ratio but was no longer statistically 
significant. This is most likely due to the low mortality rate after hospital discharge following 
CABG, making it difficult to detect a statistically significant effect. This analysis would benefit 
from a repetition with additional data from a larger patient cohort.  
Bias was limited as much as possible. We believe that researcher bias is a non-issue as these 
findings were not our expected results, but rather, the opposite. Sampling bias was also minimal. 
Our inclusion criteria were predefined prior to sampling the database. We also performed 
multiple sensitivity analyses to determine if those that were excluded would have had an effect 
on our results.  However, the study has several limitations inherent in any retrospective analysis 
of electronic health records. We recognize that correlation does not equal causation and further 
research is needed to determine the underlying physiologic mechanism for the results seen. Due 
to the self-reported nature of the pain scores, reporting bias is a concern. Some patients may have 
over-reported their pain while others under-reported their pain depending on their past 
experiences. We also recognize that the amount of pain medication administered is a confounder. 
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While we were unable to directly control for this due to lack of information regarding anesthetic 
and pain management in the database, we attempted to limit this potential confounder by 
excluding those with prolonged intubations who would inherently have received and required 
greater doses of sedatives and analgesics. Despite measures taken to guarantee internal validity, 
we anticipate appropriate skepticism with regard to generalizability of the findings beyond the 
highly selected group of patients who did well after CABG in the study. This, of course, is of 
genuine concern given the current state-of-affairs where clinicians are already inundated with 
conflicting studies of questionable quality. We therefore invite other investigators to replicate 
(and expand) our analysis in other databases. 
As noted, our findings were contrary to clinical expectations and to most published works which 
associate increased pain with worse outcomes.11,15-16 Encountering counterintuitive results is not 
unique to retrospective data analysis.  Clinicians encounter unexpected, possibly aberrant values 
in a number of situations, especially in the evaluation of laboratory and device (e.g. monitor) 
data. When a possibly spurious lab result is obtained, the most frequent response is to repeat the 
test, as many of us were trained to do.  Our responses to the repeated values would likely be of 
interest to behavioral economists who would spot confirmation bias when the second test came 
back with a more acceptable value and we then went about our business ignoring the unexpected 
value. But what if the second value comes back at the same or similar aberrant level?  Do we 
repeat it again, or do we begin to believe that the value is ‘real’ and start to formulate a response 
to a potentially serious clinical problem?  In this case, it is the consistency and reproducibility of 
the counterintuitive value that drives its possible validity, and the nature of this process is 
determined by the overall clinical danger (acuity, severity, treatability) of that value being truly 
real.  The consistency we found in the pain score values also drove us to consider the possibility 
that the values were ‘real’ even though they were counterintuitive in terms of our expectations.  
Since we were analyzing data retrospectively, we were not in a position to attempt to reproduce 
the values, but this is a possible target for future research. 
Another factor that will drive the approach to counterintuitive values is whether they are 
possible.  Impossible values would include items such as a potassium of 64.5 or a CVP of 700- 
these are simply impossible values.  But a potassium of 7.3 or a CVP of 28 are both possible 
(and very worrisome) values. The pain values we obtained in the better outcome were higher 
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than expected, but not so high that we would expect these patients to be screaming in agony.  In 
other words, while unexpected and perhaps unusual, they were not impossible in the context in 
which we observed them. 
One question that would arise with a potassium of 7.3 would be that of continuity- did the value 
occur suddenly in the context of normal values, or did it occur in the context of gradually or even 
consistently abnormal values?  In the context of persistently very abnormal values, e.g. untreated 
uremia, it would be the normal value that might appear counterintuitive.  So that while most 
counterintuitive values will tend to be out of the ‘normal range’, they will not necessarily be so. 
In the context of increasing values, it might simply be the first one that was not only out of the 
range of normal values, but had crossed the line into what might be considered the range of 
critical values,  
The question arises whether counterintuitive results are actually false, and therefore 
misleading, results.  Table Three shows a categorization of the types of errors that could 
result in faulty data.  Human error has always been a possibility in data entry but may 
even be exacerbated by problems at the human- computer interface. It is unlikely that the 
entries we observed were due to a fundamental misunderstanding of the pain scale as they 
were entered by multiple users over a prolonged period of time. Our particular example 
was not one of laboratory or device error, but these are likely the most common sources 
of what appear to be faulty data for the reasons listed in the table. Once the human (or 
interface engine) has entered the data in the software, a number of problems can then 
intervene including software, hardware, systems, and data analytic errors. We are not able 
to attribute the counterintuitive data we observed to any of these factors, however. 
There are multiple steps that should be taken following the detection of counterintuitive results in 
retrospective data analysis. While able three displays the issues to be addressed,  Table four 
displays a suggested organization of the characterization of reliable vs faulty data that should be 
kept in mind when confronted with counterintuitive data. The first step is to retrace the process 
and workflow involved in data entry so far as this is possible. The data we studied was obtained 
at the institution of several of the authors where nurses are trained to assess pain on a standard 
scale from 0 to 10. There are several potential faults to this method. The nursing staff could 
neglect to regularly assess pain or they may neglect to enter the information into the medical 
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record from which the database is derived. While this may alter a few data points, it is unlikely to 
systematically affect all the data unless there was an obvious glaring institutional issue affecting 
every nurse and every data entry.  
After determining that the data source is sound and valid, additional statistical tests can be run on 
the patient cohort. Tests, such as falsification hypothesis testing as demonstrated in the case, can 
add validity to the results if it can be shown that the cohort follows other generally known 
principles. In the case of falsification hypothesis testing, one shows that factors with no known 
effect on the outcomes of interest do not have an association in the analytic cohort. In our case 
we used nausea, which is a common side effect experienced by many in hospital patients that 
does not have any known effect on hospital LOS or mortality. In some cases, one could also 
employ concurrent contextual data to help confirm the veracity of data- for example, one could 
examine ECG tracings if hyperkalemia was the counterintuitive result being analyzed.  In order 
to do this, we examined concomitant vital signs during the time of pain measurements. We 
would have liked to have observed significant increases in heart rate, respiratory rate, and blood 
pressure associated with higher pain levels, but in fact, we did not:With the combination of the 
use of analgesics, residual anesthetic agents, and the concurrent use of drugs that directly affect 
vital signs such as beta-blockers, the lack of correlation is probably not surprising. In this setting, 
it appears to be inadvisable to use vital sign changes as a proxy for the presence of unvoiced 
pain. Finally, one can attempt to physiologically explain the disparity between the observed and 
expected results as we did above for the case of post- CABG pain being greater in more vigorous 
patients with more robust metabolic capabilities. 
In addition to the issues mentioned in the introduction, the use of lower thresholds for blood 
transfusions in the ICU is an example of a counterintuitive finding. Prior to this work, ICU target 
hemoglobin and hematocrit levels were set at greater than 10 g/dL and 30% respectively, 
theoretically to ensure adequate oxygen delivery.17 This led to increased transmission of blood 
borne diseases, unnecessary healthcare expenditures, and actually worse outcomes.18 Data later 
showed that this 10/30 rule was not necessary for most patients, but only for selected patients 
such as those with acute coronary syndrome whose hemoglobin is less than 10g/dL and actively 
experiencing chest pain. The initially counterintuitive findings that lower hemoglobin levels 
were not only acceptable but preferable in most cases, served as research triggers to more fully 
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elucidate what was truly occurring in this context. Our case may serve as an analogous research 
trigger in terms of optimally managing postoperative pain. Outcomes such as mortality and LOS 
are complex phenomena driven by many factors- to observe a clear and robust statistical effect 
such as we observed is strongly suggestive that something ‘real’ is occurring even if the data are 
counterintuitive and we don’t understand all the myriad factors that may have contributed to the 
outcomes observed. 
The final step when dealing with counterintuitive data is to look for additional evidence that 
confirms the reliability of the results (perhaps this could be termed ‘confirmatory metadata’). 
With respect to our CABG case, the analysis should be rerun on additional databases and in 
different settings to confirm or refute our initial results.  Just as clinicians continued to manage 
intensive care unit anemia as they always had until more definitive results were reported, our 
results should not impact the analgesic care of patients at this point.  However, we hope that we 
have raised the issue in the appropriate minds that outcomes may benefit from approaches 
slightly different from usual.  After all, one can easily eliminate all pain from postoperative 
patients but they would have to remain sedated and ventilated for an indefinite period of time to 
do so.  And after they are extubated, pain management should not be so aggressive that it leads to 
apnea and respiratory arrest.  In other words, there may be a mild level of tolerable pain that 
leads patients to their best outcomes, and no honest clinician will guarantee a patient that they 
will have no pain at all after a procedure like a sternal-disrupting CABG. 
Conclusion 
Contrary to our expectations, we observed, in a retrospective analysis of electronic health 
records, that post-CABG fast-track patients with higher pain scores had better outcomes. The 
increasing use of EHRs for secondary analysis will likely lead to an increasing incidence of such 
apparently counterintuitive results. While the first step in this situation is to attempt to confirm 
the reliability of both the analytic process and the data itself, such findings that prove to be 
robust may lead to further ideas and subsequent research that drive future clinical care. On the 
other hand, clinicians must be careful in terms of modifying their practices until the implications 
of such counterintuitive (or any) data have been thoroughly vetted and confirmed in diverse 
database contexts and via the peer review process. 
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Figures 
 
Figure 1: Patient Cohort selection 
 
 
FIGURE 1: SHOWS SELECTION OF PATIENT COHORT FROM MIMIC DATABASE. AFTER 
SELECTING THOSE WHO UNDERWENT CABG PROCEDURE AND EXCLUDING THOSE WITH NO 
PAIN MEASUREMENTS; 844 PATIENTS WERE EXTUBATED WITHIN 24 HOURS FOLLOWING 
SURGERY AND INCLUDED IN THE COHORT. 
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Figure 2: Bivariate Analysis 
 
FIGURE 2: THREE PLOTS DEMONSTRATING THE BIVARIATE RELATIONSHIP BETWEEN THE OUTCOMES OF 
INTEREST AND MEAN PAIN. PLOT A SHOWS DECREASED LENGTH OF STAYS WITH INCREASED MEAN PAIN 
LEVELS. PLOT B AND PLOT C SHOW THAT, ON AVERAGE, THOSE WHO EXPIRED AT 30 DAYS AND 1 YEAR 
MARKS EXPERIENCED LOWER IN HOSPITAL PAIN LEVELS THAN THOSE WHO DID NOT EXPIRE. 
 
 
  
Page 17 of 20 
 
Tables 
Table 1: Cohort Characteristics  
TABLE 1: SHOWS THE DISTRIBUTION OF THE OUTCOMES AND COVARIATES IN THE PATIENT COHORT.  
ABBREVIATIONS: OASIS = OXFORD ACUTE SEVERITY OF ILLNESS SCORE; E_SCORE = ELIXHAUSER 
SCORE. 
OASIS SCORES RANGE FROM 0 TO 75, WITH HIGHER SCORES INDICATING MORE SEVERE DISEASE; 
ELIXHAUSER SCORE WAS BASED ON AGGREGATE PRESENCE OR ABSENCE OF CONDITIONS IN ELIXHAUSER 
COMORBIDITY INDEX. COUNTS RANGED FROM 0 TO 9. 
 
 No Pain Mild Moderate Severe p 
n 68 419 336 21  
Age (mean (sd)) 71.50 (10.61) 67.75 (10.54) 64.98 (9.73) 65.13 (12.85) <0.001 
Gender = male 45 (66.2) 333 (79.5) 282 (83.9) 14 (66.7) 0.003 
oasis (mean (sd)) 31.96 (7.25) 30.32 (6.47) 31.44 (6.35) 30.57 (6.20) 0.056 
e_score (%)    <0.001 
0 4 (5.9) 96 (22.9) 87 (25.9) 7 (33.3)  
1 12 (17.6) 116 (27.7) 97 (28.9) 4 (19.0)  
2 12 (17.6) 81 (19.3) 79 (23.5) 4 (19.0)  
3 10 (14.7) 61 (14.6) 46 (13.7) 3 (14.3)  
4 12 (17.6) 29 (6.9) 16 (4.8) 1 (4.8)  
5 6 (8.8) 19 (4.5) 8 (2.4) 2 (9.5)  
6 7 (10.3) 8 (1.9) 2 (0.6) 0 (0.0)  
7 2 (2.9) 4 (1.0) 1 (0.3) 0 (0.0)  
8 0 (0.0) 4 (1.0) 0 (0.0) 0 (0.0)  
9 3 (4.4) 1 (0.2) 0 (0.0) 0 (0.0)  
Mortality      
In Hospital 9 (13.2) 5 (1.2) 1 (0.3) 0 (0.0) <0.001 
30 Day 10 (14.7) 10 (2.4) 1 (0.3) 0 (0.0) <0.001 
1 Year 16 (23.5) 22 (5.3) 7 (2.1) 1 (4.8) <0.001 
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Table 2: Primary Outcome Results 
TABLE 2: SHOWS RESULTS FROM MAIN ANALYSIS AND THE TWO SENSITIVITY ANALYSES.  
*, **, *** DENOTES SIGNIFICANCE AT THE 90%, 95%, AND 99% LEVEL, RESPECTIVELY. 
 
 
Model 
30 Day Mortality Odds 
(95% Confidence Interval) 
1 Year Mortality Odds 
(95% Confidence Interval) Length of Stay Estimate 
Primary Analysis: 
  
Mean Pain 0.457***  
(0.304 – 0.687) 
0.710***  
(0.571 - 0.881) 
-0.916*** 
 
Median Pain 0.639***  
(0.466 - 0.877) 
0.856*  
(0.727 - 1.008) 
-0.696*** 
Max Pain 0.812***  
(0.693 - 0.951) 
0.887**  
(0.790- 0.995) 
0.148* 
Categorical Pain 
 
0.214***  
(0.091 - 0.502) 
0.450*** 
(0.266 - 0.760) 
-2.270*** 
Sensitivity Analysis 1: Including all patients regardless of intubation length 
Mean Pain 0.592*** 
(0.456 - 0.768) 
0.898 
(0.785 - 1.027) 
-0.709*** 
Categorical Pain 
 
0.328*** 
(0.184 - 0.586) 
0.740* 
(0.527 - 1.037) 
-1.706*** 
 
Sensitivity Analysis 2: Excluding hospital mortality patients 
Mean Pain 0.803 
(0.567 - 1.137) 
1.027  
(0.889 - 1.187) 
-0.701*** 
 
Categorical Pain 
 
0.709 
(0.309 - 1.625) 
1.038 
(0.714 - 1.509) 
-1.680*** 
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Table 3: Putative Reasons for Truly Faulty Data 
Human error Mis-entry; misunderstanding of scale values; 
faulty understanding of use of data entry 
software; faulty interpretation of device 
values 
Lab error Sampling error (eg hemolysis); measurement 
error 
Device error Disconnect, interference, faulty calibration, 
software error; unexplained, transient aberrant 
values that resolve and do not recur 
Systems error Interface error, application interoperability 
error 
Software error Bug in software relating to data value entry; 
data wrongly captured, stored, and/or 
retrieved due to software design faults or bugs 
Hardware error Hardware issues that impact software and 
systems 
Data analytic error Error in analytic algorithm or process 
 
Table 4: Criteria to establish possible validity of counterintuitive data 
Viability Is the value consistent with clinical reality? 
Are the values even possible ones? 
Consistency If applicable (not always the case in 
retrospective analysis), is the value observed 
consistently, such as in our pain score 
observations? 
Continuity What is the context of the value- does it occur 
as a sudden aberrant value, or as one of 
increasingly aberrant values? 
Identity Are the circumstances that produced the data 
truly identical so far as identifiable? Ie. 
Would the same circumstances produce the 
same data results in a different database, 
institutional, or cultural context? 
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Reproducibility Is the value reproducible on repetition? while 
reproduction can not be performed in 
retrospective data, can it be reproduced upon 
observation across different clinical databases 
Sensibility Even if it does not meet current clinical 
expectations and is possible, does it make 
potential sense in associated clinical context? 
Curiosity Does it drive the observer to seek alternative 
better solutions and pose questions for further 
research? 
 
